Correlation Between Madrigal Pharmaceuticals and Marinus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Marinus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Marinus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Marinus Pharmaceuticals, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Marinus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Marinus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Marinus Pharmaceuticals.

Diversification Opportunities for Madrigal Pharmaceuticals and Marinus Pharmaceuticals

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Madrigal and Marinus is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Marinus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marinus Pharmaceuticals and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Marinus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marinus Pharmaceuticals has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Marinus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Marinus Pharmaceuticals

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.99 times more return on investment than Marinus Pharmaceuticals. However, Madrigal Pharmaceuticals is 1.01 times less risky than Marinus Pharmaceuticals. It trades about 0.34 of its potential returns per unit of risk. Marinus Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  21,700  in Madrigal Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of  12,818  from holding Madrigal Pharmaceuticals or generate 59.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Marinus Pharmaceuticals

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Marinus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Marinus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Madrigal Pharmaceuticals and Marinus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Marinus Pharmaceuticals

The main advantage of trading using opposite Madrigal Pharmaceuticals and Marinus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Marinus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marinus Pharmaceuticals will offset losses from the drop in Marinus Pharmaceuticals' long position.
The idea behind Madrigal Pharmaceuticals and Marinus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios